4-Hydroxyandrostenedione in the prophylaxis of N-methyl-N-nitrosourea induced mammary tumourigenesis.

We have examined the role of the aromatase inhibitor 4-hydroxyandrostenedione (4-OHA) in the prevention of mammary tumourigenesis in experiments involving 170 rats. We first demonstrated a prophylactic effect of 4-OHA (50 mg/week) in reducing tumour incidence over a 30 week period compared to contro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Coombes, R. C., Wilkinson, J. R., Bliss, J. M., Shah, P., Easton, D. F., Dowsett, M.
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 1991
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1977518/
https://ncbi.nlm.nih.gov/pubmed/1892751
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares